Business

Robert Lacaze joins Summit Therapeutics as chief commercial officer

  • Summit Therapeutics (NASDAQ:SMMT) has appointed Robert LaCaze as chief commercial officer, reporting to Manmeet S. Soni, chief operating officer and chief financial officer, effective immediately.
  • LaCaze is a seasoned biopharmaceutical executive with over 35 years of extensive leadership experience in commercial strategy and execution, the company said.
  • He has held senior positions at major pharmaceutical companies like Bayer Healthcare and Bristol-Myers Squibb.
  • Source: Press Release

https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png

2025-03-17 15:37:25

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button